1GNG | Glycogen synthase kinase-3 beta (GSK3) complex with FRATtide peptide | date | ![]() |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Bax, B., Carter, P.S., Lewis, C., Guy, A.R., Bridges, A., Tanner, R., Pettman, G., Mannix, C., Culbert, A.A., Brown, M.J.B., Smith, D.G., Reith, A.D. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.60 | ||||||||||||
ligand | PTR, SO4, TRS | enzyme |
| ||||||||||||
note | 1GNG is a representative structure | ||||||||||||||
related structures | by homologous chain: 1I09, 1O9U | ||||||||||||||
Gene Ontology ![]() |
| ||||||||||||||
Primary reference | The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation., Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ, Smith DG, Reith AD, Structure (Camb) 2001 Dec;9(12):1143-52. PMID:11738041 |
Data retrieval |
![]() |
View 1GNG in 3D |
![]() |
Visual 3D analysis of 1GNG |
Structure-derived information |
- Domain d1gnga_, region A [Jmol] [rasmolscript] [script source] - Domain d1gngb_, region B [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1GNG |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |